The data presented at SABCS further validates the best-in-class performance of Pathlight, SAGA’s structural-variant–based MRD ...
SAGA Diagnostics, a pioneer in blood-based cancer detection and precision medicine redefining the standard for ultra-sensitive and early molecular residual disease (MRD) detection, will present five ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback